related announcements

News

SES AI Corporation

Statement of Changes in Beneficial Ownership - Form 4
Regent University

Regent University Announces a Campus Expansion at Inaugural RoyalsFest[...]
SS Innovations International Inc.

Revolutionizing Surgery: SS Innovations International Inc. Celebrates[...]

Healthcare

EPR Properties

EPR Properties Announces New $1.0 Billion Revolving Credit Facility[...]
Context Therapeutics Inc.

BioAtla and Context Therapeutics Announce Exclusive Worldwide License[...]
Cincinnati Children's Hospital[...]

Cincinnati Children’s acquires office building in Cincinnati Innovation[...]

4D Molecular Therapeutics Inc.

09/23/2024 | Press release | Distributed by Public on 09/23/2024 06:06

4DMT Announces Presentation at the 2024 North American Cystic Fibrosis Conference

Read this content

Click here to read the original version at the source's official website. The text of this article is not available at the moment.

Sharing and Personal Tools

Please select the service you want to use:

Smartlinks | 4D Molecular Therapeutics Inc. | News | Health | Company News | Top Company News | Pharmaceuticals | Biotechnology and Medical Research Companies | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago

Back